Monovalent XBB.1.5 COVID|19 vaccine effectiveness against ...

Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5 ...

1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent ...

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against ...

Conclusion: Monovalent XBB.1.5 vaccine had a moderate protective effect against severe and fatal COVID-19 likely caused by BA.2.86/JN.1 during ...

Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID ...

Effectiveness of updated 2023–2024 (monovalent XBB.1.5) COVID-19 vaccination against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineage hospitalization.

Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) - CDC

Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection ...

Comparing the COVID-19 Vaccines: How Are They Different?

In 2022, “bivalent” vaccines targeted both the original virus and Omicron variants BA.4 and BA.5; in 2023, a monovalent shot targeted the XBB ...

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against ...

Monovalent XBB.1.5 vaccine had a moderate protective effect against severe COVID-19 likely caused by BA.2.86/JN.1 during the 2023/2024 winter, among persons ...

XBB.1.5 monovalent mRNA vaccine booster elicits robust ...

COVID-19 vaccines have recently been updated to specifically encode or contain the spike protein of the SARS-CoV-2 XBB.1.5 subvariant, ...

Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in ...

Patients with COVID-19 (cases) were less likely to have received the XBB.1.5 monovalent vaccine (case 3.5% vs. control 7.2%, p=0.019) and to have a history of ...

Effectiveness of XBB.1.5 vaccines and antiviral drugs against severe ...

... COVID-19 vaccines containing a monovalent component of the XBB.1.5 variant “to provide better protection against serious consequences of ...

Effectiveness of XBB.1.5 monovalent COVID-19 vaccine against ...

Recent booster vaccination with the XBB.1.5 monovalent COVID-19 vaccine is highly effective in preventing COVID-19 mortality.

Estimated Effectiveness of the BNT162b2 XBB Vaccine Against ...

Thus, on September 11, 2023, the US Food and Drug Administration authorized or approved updated monovalent messenger RNA (mRNA) COVID-19 ...

Full article: Monovalent XBB.1.5 COVID-19 vaccine effectiveness ...

We aimed to estimate XBB.1.5 vaccine effectiveness (VE) against COVID-19-related hospitalizations and deaths during BA.2.86/JN.1 predominance, among EU/EEA ...

Expert Opinion: A FAQ on COVID-19 subvariant XBB.1.5

Are current mRNA vaccines effective against XBB.1.5? XBB.1.5 and XBB.1 are ... vaccines still perform better than monovalent vaccines against XBB.1.5 ...

Monovalent XBB.1.5 vaccine shows 51% protection against COVID ...

The monovalent (single-strain) XBB.1.5 COVID-19 vaccine shows the shot was 51% effective in preventing emergency department and urgent care visits among adults ...

Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine ...

1.5 vaccine, at least in the short term; vaccination was associated with a 76·1% reduced risk of COVID-19 hospitalisation in a population ...

Estimates of vaccine effectiveness of the updated monovalent XBB ...

1.5 vaccine against symptomatic COVID-19 infection, hospitalization, and the need for oxygen therapy in South Korea. Design. This study employed ...

Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID ...

Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage ...

The Updated COVID Vaccines Are Here: 9 Things to Know

... vaccine is monovalent, designed to prevent severe disease from the Omicron XBB.1.5 subvariant. By September 2023, the long-running XBB.1.5 ...

WHO advisers recommend sticking with monovalent COVID XBB.1.5 ...

... 19 had been fully vaccinated against COVID-19 at the time of ... vaccine effectiveness against pneumococcal disease," the authors wrote.

Monovalent XBB.1.5 Vaccine Is Effective Against XBB, JN Lineage ...

The monovalent XBB.1.5 COVID-19 vaccine is effective against XBB and JN lineage hospitalization; however, protection against the latter may ...